Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cottler-Fox

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Annals of the New York Academy of Sciences|May 31, 1994
Gene transfer into hematopoietic cells. Implications for cancer therapyC E Dunbar, D M Bodine, B Sorrentino, et al.
Bone Marrow Transplantation|May 11, 2004
High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicityI Gojo, C Guo, C Sarkodee-Adoo, et al.
Bone Marrow Transplantation|January 26, 2006
Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantationC-K Lee, M Zangari, A Fassas, et al.
British Journal of Haematology|February 13, 2001
Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphomaA B Fassas, J Bolaños-Meade, L N Buddharaju, et al.
Blood|December 3, 1998
A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host diseaseD Przepiorka, G L Phillips, V Ratanatharathorn, et al.
Blood|June 1, 1995
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantationC E Dunbar, M Cottler-Fox, J A O'Shaughnessy, et al.
Human Gene Therapy|April 1, 1993
Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancerC E Dunbar, A W Nienhuis, F M Stewart, et al.
Seminars in Hematology|July 1, 1992
Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantationT R Spitzer, M Cottler-Fox, P Sullivan, et al.
Bone Marrow Transplantation|January 10, 2006
Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipientsM L Grazziutti, L Dong, M H Miceli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumorsW H Wilson, V Jain, G Bryant, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Annals of the New York Academy of Sciences|May 31, 1994
Gene transfer into hematopoietic cells. Implications for cancer therapyC E Dunbar, D M Bodine, B Sorrentino, et al.
Bone Marrow Transplantation|May 11, 2004
High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicityI Gojo, C Guo, C Sarkodee-Adoo, et al.
Bone Marrow Transplantation|January 26, 2006
Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantationC-K Lee, M Zangari, A Fassas, et al.
British Journal of Haematology|February 13, 2001
Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphomaA B Fassas, J Bolaños-Meade, L N Buddharaju, et al.
Blood|December 3, 1998
A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host diseaseD Przepiorka, G L Phillips, V Ratanatharathorn, et al.
Blood|June 1, 1995
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantationC E Dunbar, M Cottler-Fox, J A O'Shaughnessy, et al.
Human Gene Therapy|April 1, 1993
Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancerC E Dunbar, A W Nienhuis, F M Stewart, et al.
Seminars in Hematology|July 1, 1992
Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantationT R Spitzer, M Cottler-Fox, P Sullivan, et al.
Bone Marrow Transplantation|January 10, 2006
Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipientsM L Grazziutti, L Dong, M H Miceli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumorsW H Wilson, V Jain, G Bryant, et al.
Pageof 9